Practical and in-depth content on pharmaceutical regulatory requirements across global markets. Learn about submissions, approvals, variations, labeling, and health authority expectations with real-world examples.
Have you ever wondered why medicines approved in one country often meet similar quality, safety, and efficacy standards elsewhere? That consistency didn’t happen by accident. It’s the result of years of collaboration, negotiation, and—believe it or not—frustration among global regulators […]
Story Behind the Formation of ICH Read More »
If you’ve ever wondered how some drugs reach the US market faster than brand-new molecules, you’re about to uncover one of the smartest regulatory shortcuts—the 505(b)(2) pathway. No, it’s not a loophole.No, it’s not a compromise on safety. Think of
New Drug Approvals: 505(b)(2) Pathway in the USA Read More »
Navigating the United States Food and Drug Administration (FDA) drug approval process can be a complex, time-consuming journey, yet it is a critical step for pharmaceutical companies seeking to bring innovative and life-saving drugs to market. The FDA’s rigorous approval
A Guide to the US FDA Approval Process for Drugs Read More »
When did companies announce the drug recall? Companies announce drug recalls as soon as they become aware of a problem with their product. As a result, prescription or over-the-counter medicine is removed from the market because it is found to
Drug Recall: Understanding Its Types, Classes, Levels, and Examples Read More »
What is an FDA 483? The FDA 483 form is used by the FDA inspector to document inspection observations made during the inspection which are generally called 483s. This Form 483 is used to list findings or practices that are
FDA 483, Warning Letter, Import Alert, and Consent Decree: Understanding the Differences Read More »
